NENF

Across TCGA pan-cancer cohorts, NENF mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of NENF’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where NENF mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types NENF is over-expressed in tumor, although a few such as CCRCC and PDAC show the opposite, repressed pattern.

CCRCC, LUAD, and LSCC are the cancer types where NENF tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NENF mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	III,IV	−0.457	<.001	10	view →
LUAD	Male	II,III,IV	+0.899	<.001	9	view →
LSCC	Female	All	+0.647	<.001	9	view →
HNSC	Male	III,IV	+0.256	<.001	8	view →
PDAC	Male	II,III,IV	−0.414	<.001	4	view →
COAD	All	IV	−0.339	.008	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

NENF–CCRCC

Open the CCRCC breakdown →